CC BY 4.0 · SynOpen 2024; 08(02): 125-129
DOI: 10.1055/s-0040-1720118
letter

Oxidative C–N Bond Formation of Isochromans Using an Electronically Tuned Nitroxyl Radical as Catalyst

Kyoko Yano
a   Laboratory of Pharmaceutical Chemistry, Kyoto Pharmaceutical University, Yamashinaku, Kyoto 607-8412, Japan
,
Ayano Ohshimo
a   Laboratory of Pharmaceutical Chemistry, Kyoto Pharmaceutical University, Yamashinaku, Kyoto 607-8412, Japan
,
Elghareeb E. Elboray
a   Laboratory of Pharmaceutical Chemistry, Kyoto Pharmaceutical University, Yamashinaku, Kyoto 607-8412, Japan
b   Department of Chemistry, Faculty of Science, South Valley University, Qena 83523, Egypt
,
Yusuke Kobayashi
a   Laboratory of Pharmaceutical Chemistry, Kyoto Pharmaceutical University, Yamashinaku, Kyoto 607-8412, Japan
,
Takumi Furuta
a   Laboratory of Pharmaceutical Chemistry, Kyoto Pharmaceutical University, Yamashinaku, Kyoto 607-8412, Japan
,
Shohei Hamada
a   Laboratory of Pharmaceutical Chemistry, Kyoto Pharmaceutical University, Yamashinaku, Kyoto 607-8412, Japan
› Author Affiliations
This study was supported by Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT KAKENHI) grants 19K16327 and 21K06487 (to S.H.).


Abstract

The cross-dehydrogenative coupling between isochromans and nucleophiles using an electronically tuned nitroxyl radical catalyst, which effectively promotes the oxidation of benzylic ethers, has been investigated. Using sulfonamides as a nucleophile, modification of isochromans via oxidative C–N bond formation has been achieved at ambient temperature.

Supporting Information



Publication History

Received: 31 March 2024

Accepted after revision: 24 April 2024

Article published online:
13 May 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References and Notes

    • 1a Grove JF, Pople J. J. Chem. Soc., Perkin Trans. 1 1979; 2048
    • 1b Papillon JP. N, Adams CM, Hu Q-Y, Lou C, Singh AK, Zhang C, Carvalho J, Rajan S, Amaral A, Beil ME, Fu F, Gangl E, Hu C.-W, Jeng AY, LaSala D, Liang G, Logman M, Maniara WM, Rigel DF, Smith SA, Ksander GM. J. Med. Chem. 2015; 58: 4749
    • 1c Zhang H, Matsuda H, Kumahara A, Ito Y, Nakamura S, Yoshikawa M. Bioorg. Med. Chem. Lett. 2007; 17: 4972

      For examples of the oxidation of isochromans using transition-metal catalysts, see
    • 2a Catino AJ, Nichols JM, Choi H, Gottipamula S, Doyle MP. Org. Lett. 2005; 7: 5167
    • 2b Gonzalez de Castro A, Robertson CM, Xiao J. J. Am. Chem. Soc. 2014; 136: 8350
    • 2c Wang Y, Kuang Y, Wang Y. Chem. Commun. 2015; 51: 5852
    • 2d Yang Y, Ma H. Tetrahedron Lett. 2016; 57: 5278
    • 2e Tanaka H, Oisaki K, Kanai M. Synlett 2017; 28: 1576
    • 2f Hong C, Ma J, Li M, Jin L, Hu X, Mo W, Hu B, Sun N, Shen Z. Tetrahedron 2017; 73: 3002

      For examples of cross-dehydrogenative coupling reactions using transition-metal catalysts, see:
    • 3a Zhang Y, Li C.-J. Angew. Chem. Int. Ed. 2006; 45: 1949
    • 3b Richter H, Rohlmann R, Mancheño OG. Chem. Eur. J. 2011; 17: 11622
    • 3c Zhang Z, Tu Y.-Q, Zhang X.-M, Zhang F.-M, Wang S.-H. Org. Chem. Front. 2019; 6: 2275

      For examples of the oxidation of isochromans using organocatalysts, see:
    • 4a Zhang Z, Gao Y, Liu Y, Li J, Xie H, Li H, Wang W. Org. Lett. 2015; 17: 5492
    • 4b Thatikonda T, Deepake SK, Kumar P, Das U. Org. Biomol. Chem. 2020; 18: 4046
    • 4c Thapa P, Hazoor S, Chouhan B, Vuong TT, Foss FW. Jr. J. Org. Chem. 2020; 85: 9096
    • 4d Hamada S, Yano K, Kobayashi Y, Kawabata T, Furuta T. Tetrahedron Lett. 2021; 83: 153404

      For examples of the cross-dehydrogenative coupling of isochromans using organocatalysts, see:
    • 5a Muramatsu W, Nakano K, Li C.-J. Org. Lett. 2013; 15: 3650
    • 5b Muramatsu W, Nakano K. Org. Lett. 2015; 17: 1549
    • 5c Mao Y, Cao M, Pan X, Huang J, Li J, Xu L, Liu L. Org. Chem. Front. 2019; 6: 2028
    • 7a Iwabüchi Y. Chem. Pharm. Bull. 2013; 61: 1197
    • 7b Shibuya M. Tetrahedron Lett. 2020; 61: 151515
    • 8a Ciriminna R, Pagliaro M. Org. Process Res. Dev. 2010; 14: 245
    • 8b Sasano Y, Sato H, Tadokoro S, Kozawa M, Iwabüchi Y. Org. Process Res. Dev. 2019; 23: 571
  • 9 Nagasawa S, Sasano Y, Iwabüchi Y. Heterocycles 2022; 105: 61
  • 10 Hamada S, Furuta T, Wada Y, Kawabata T. Angew. Chem. Int. Ed. 2013; 52: 8093
  • 11 Catalyst 2 can be used in the oxidation of isochroman on a gram scale; for details, see ref. 4d
    • 12a Hamada S, Sugimoto K, Elboray EE, Kawabata T, Furuta T. Org. Lett. 2020; 22: 5486
    • 12b Hamada S, Sumida M, Yamazaki R, Kobayashi Y, Furuta T. J. Org. Chem. 2023; 88: 12464
  • 13 A small amount of 1-isochromanone was also produced as a byproduct.
  • 14 In the absence of 1, no product was obtained

    • Weak inorganic bases probably neutralize trifluoroacetic acid derived from PIFA slowly in dichloromethane, whereas organic bases are much faster. The differences in solution acidity may affect the reactivity and selectivity of the oxidation catalyzed by 2. For examples of the acidity affecting the reactivity of the oxidation mediated by nitroxyl-radical catalysts or oxoammonium salts, see:
    • 15a Bailey WF, Bobbitt JM, Wiberg KB. J. Org. Chem. 2007; 72: 4504
    • 15b Hamada S, Sakamoto K, Miyazaki E, Elboray EE, Kobayashi Y, Furuta T. ACS Catal. 2023; 13: 8031
    • 16a De Mico A, Margarita R, Parlanti L, Vescovi A, Piancatelli G. J. Org. Chem. 1997; 62: 6974
    • 16b De Luca L, Giacomelli G, Porcheddu A. Org. Lett. 2001; 3: 3041
  • 17 The hydride-transfer step has already been proposed as the rate-determining step in the oxidation of isochromans to the corresponding oxocarbenium cations; for details, see ref. 4d.
  • 18 General Procedure PIFA (103 mg, 0.240 mmol) was added to a mixture of isochroman (26.8 mg, 200 mmol), 2 (4.6 mg, 20 μmol), K2CO3 (111 mg, 0.800 mmol), and sulfonamide (0.400 mmol) in DCM (2.0 mL). The resulting mixture was stirred under N2 atmosphere for 2 h at room temperature. Then, the reaction was quenched with saturated aq. Na2S2O3 and extracted with CHCl3. Subsequently, the organic layer was dried over Na2SO4, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography.
  • 19 Representative Spectral Data N-(Isochroman-1-yl)-4-methyl­benzenesulfonamide (3)1 The title compound 3 (38.0 mg, 63%) was synthesized from isochroman (26.8 mg, 0.200 mmol) and 4-methylbenzenesulfonamide (68.5 mg, 0.400 mmol). Colorless solid; mp 178–181 °C. 1H NMR (500 MHz, CDCl3): δ = 7.86 (d, J = 8.5 Hz, 2 H), 7.31 (d, J = 7.9 Hz, 2 H), 7.26–7.18 (m, 3 H), 7.08 (d, J = 7.2 Hz, 1 H), 6.10 (d, J = 8.6 Hz, 1 H), 5.40 (d, J = 8.6 Hz, 1 H), 3.73–3.57 (m, 2 H), 2.85 (ddd, J = 15.9, 9.7, 6.0 Hz, 1 H), 2.61 (dt, J = 16.7, 4.0 Hz, 1 H), 2.44 (s, 3 H). 13C NMR (75 MHz, CDCl3): δ = 143.40, 138.79, 134.54, 132.82, 129.52, 128.87, 128.47, 127.25, 126.84, 126.76, 79.91, 58.76, 27.58, 21.63. IR (ATR) 3202, 1328, 1157, 748 cm–1. HRMS (ESI): m/z [M + Na]+ calcd for C16H17NNaO3S: 326.0827; found: 326.0829.